C3 glomerulopathy: a new classification

被引:243
作者
Fakhouri, Fadi [2 ]
Fremeaux-Bacchi, Veronique [3 ]
Noel, Laure-Helene [4 ]
Cook, H. Terence [1 ]
Pickering, Matthew C. [1 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, CCIR, Fac Med, Div Immunol & Inflammat, London W12 0NN, England
[2] CHU Nantes, INSERM, Dept Nephrol, UMR643, F-44000 Nantes, France
[3] Hop Europeen Georges Pompidou, Serv Immunol Biol, F-75015 Paris, France
[4] Hop Necker Enfants Malad, INSERM, U845, F-75015 Paris, France
关键词
DENSE-DEPOSIT DISEASE; HEMOLYTIC-UREMIC SYNDROME; COMPLEMENT FACTOR-H; GLOMERULONEPHRITIS TYPE-III; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MESANGIOCAPILLARY GLOMERULONEPHRITIS; CHILDREN; VARIANT;
D O I
10.1038/nrneph.2010.85
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Several distinct pathological patterns of glomerular inflammation are associated with abnormal regulation of the complement system, specifically, with dysregulation of the alternative pathway of the complement system. However, these conditions share the pathological finding of complement C3 (C3) deposited within the glomerulus in the absence of substantial immunoglobulin. This finding has alerted us and others to the possible presence of genetic and acquired complement dysregulation in individual patients. This article summarizes our current understanding of the relationship between dysregulation of the complement system and glomerular inflammation. Here, we suggest that glomerular pathologies that are characterized by the isolated deposition of C3 could usefully be classified by the term C3 glomerulopathy. In our view, this classification would alert the pathologist and nephrologist to the importance of screening for acquired and genetic abnormalities in complement regulation. In the future, it could help to identify individuals who might benefit from therapeutic inhibition of the complement system.
引用
收藏
页码:494 / 499
页数:6
相关论文
共 29 条
[1]  
ALCHI B, PEDIATR NEPHROL, DOI DOI 10.1007/S00467-009-1322-1327
[2]   Membranoproliferative glomerulonephritis type II (dense deposit disease):: An update [J].
Appel, GB ;
Cook, HT ;
Hageman, G ;
Jennette, JC ;
Kashgarian, M ;
Kirschfink, M ;
Lambris, JD ;
Lanning, L ;
Lutz, HU ;
Meri, S ;
Rose, NR ;
Salant, DJ ;
Sethi, S ;
Smith, RJH ;
Smoyer, W ;
Tully, HF ;
Tully, SP ;
Walker, P ;
Welsh, M ;
Würzner, R ;
Zipfel, PF .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (05) :1392-1403
[3]   MESANGIOCAPILLARY GLOMERULONEPHRITIS TYPE-II (DENSE-DEPOSIT DISEASE) - CLINICAL-FEATURES OF PROGRESSIVE DISEASE [J].
BENNETT, WM ;
FASSETT, RG ;
WALKER, RG ;
FAIRLEY, KF ;
DAPICE, AJF ;
KINCAIDSMITH, P .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1989, 13 (06) :469-476
[4]   IDIOPATHIC MESANGIOCAPILLARY GLOMERULONEPHRITIS - COMPARISON OF TYPE-I AND TYPE-II IN CHILDREN AND ADULTS AND LONG-TERM PROGNOSIS [J].
CAMERON, JS ;
TURNER, DR ;
HEATON, J ;
WILLIAMS, DG ;
OGG, CS ;
CHANTLER, C ;
HAYCOCK, GB ;
HICKS, J .
AMERICAN JOURNAL OF MEDICINE, 1983, 74 (02) :175-192
[5]   A mutant complement factor H-related 5 protein is associated with familial C3 glomerulonephritis [J].
de Jorge, E. Goicoechea ;
Gale, D. P. ;
Cook, H. T. ;
Martinez-Barricarte, R. ;
Hadjisavvas, A. ;
Pusey, C. D. ;
Palmer, A. ;
Fremeaux-Bacchi, V. ;
Rodriguez de Cordoba, S. ;
Maxwell, P. H. ;
Pickering, M. C. .
MOLECULAR IMMUNOLOGY, 2009, 46 (14) :2822-2822
[6]  
HABIB R, 1975, KIDNEY INT, V7, P204, DOI 10.1038/ki.1975.32
[7]   Where next with atypical hemolytic uremic syndrome? [J].
Jokiranta, T. Sakari ;
Zipfel, Peter F. ;
Fremeaux-Bacchi, Veronique ;
Taylor, C. Mark ;
Goodship, Timothy J. H. ;
Noris, Marina .
MOLECULAR IMMUNOLOGY, 2007, 44 (16) :3889-3900
[8]   Complement regulatory genes and hemolytic uremic syndromes [J].
Kavanagh, David ;
Richards, Anna ;
Atkinson, John .
ANNUAL REVIEW OF MEDICINE, 2008, 59 :293-309
[9]  
LACHMANN P, 2009, ADV IMMUNOL, V149, P104
[10]   IMMUNOPATHOLOGY OF MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS WITH SUB-ENDOTHELIAL DEPOSITS (TYPE-I MPGN) [J].
LEVY, M ;
GUBLER, MC ;
SICH, M ;
BEZIAU, A ;
HABIB, R .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1978, 10 (04) :477-492